Your browser doesn't support javascript.
loading
Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL.
Hubmann, Rainer; Schnabl, Susanne; Araghi, Mohammad; Schmidl, Christian; Rendeiro, André F; Hilgarth, Martin; Demirtas, Dita; Ali, Farghaly; Staber, Philipp B; Valent, Peter; Zielinski, Christoph; Jäger, Ulrich; Shehata, Medhat.
Affiliation
  • Hubmann R; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, 1090 Vienna, Austria.
  • Schnabl S; Comprehensive Cancer Center Vienna, Drug and Target Screening Platform DTS, Medical University of Vienna, 1090 Vienna, Austria.
  • Araghi M; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, 1090 Vienna, Austria.
  • Schmidl C; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, 1090 Vienna, Austria.
  • Rendeiro AF; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
  • Hilgarth M; Regensburg Center for Interventional Immunology (RCI), Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany.
  • Demirtas D; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
  • Ali F; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, 1090 Vienna, Austria.
  • Staber PB; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, 1090 Vienna, Austria.
  • Valent P; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, 1090 Vienna, Austria.
  • Zielinski C; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, 1090 Vienna, Austria.
  • Jäger U; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, 1090 Vienna, Austria.
  • Shehata M; Ludwig Boltzmann Institute for Oncology & Hematology, Medical University of Vienna, 1090 Vienna, Austria.
Cells ; 9(6)2020 06 18.
Article in En | MEDLINE | ID: mdl-32570839
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Receptor, Notch2 / Receptor, Notch3 / Gliotoxin Type of study: Prognostic_studies Limits: Aged80 Language: En Journal: Cells Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Receptor, Notch2 / Receptor, Notch3 / Gliotoxin Type of study: Prognostic_studies Limits: Aged80 Language: En Journal: Cells Year: 2020 Document type: Article Affiliation country: Country of publication: